Vascepa (icosapent ethyl) is a prescription medication used to reduce the risk of cardiovascular events in certain adult patient groups. According to the sources provided, Vascepa can be used in combination with other medications.

DrugPatentWatch [1] provides information on the patents and exclusivities of Vascepa, but does not mention any restrictions on its use with other medications.

Drugs.com [2] provides a list of potential drug interactions with Vascepa, including medications that may increase the risk of bleeding, such as anticoagulants and antiplatelet drugs. However, the website notes that Vascepa can be taken with or without food, and that no other specific drug interactions have been identified.

The FDA [3] also approves the use of Vascepa in combination with other medications for the reduction of cardiovascular events. In fact, the FDA specifically mentions that Vascepa "may be used with other therapies that reduce the risk of cardiovascular events" in their press release announcing the drug's approval.

In summary, the sources provided indicate that Vascepa can be used in combination with other medications, although caution should be taken when combining it with drugs that increase the risk of bleeding. Patients should always consult with their healthcare provider before starting or stopping any medications.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.drugs.com/drug-interactions/icosapent,vascepa.html
[3] https://www.fda.gov/news-events/press-announcements/fda-approves-use-drug-reduce-risk-cardiovascular-events-certain-adult-patient-groups